Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
about
Lifestyle-related factors in predementia and dementia syndromesCholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian YorubaCardiovascular Risk Factors for Alzheimer's DiseaseStatins for the prevention of dementiaStatins for the treatment of dementiaStatins for the treatment of dementiaStatins for the prevention of dementiaApolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in miceLow HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II studyDiagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer diseaseLipoprotein profile in older patients with vascular dementia and Alzheimer's diseaseGlutathione and mitochondriaInsulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndromePerimenopause and cognitionDeconstructing racial differences: the effects of quality of education and cerebrovascular risk factorsDifferential contributions of ApoE4 and female sex to BACE1 activity and expression mediate Aβ deposition and learning and memory in mouse models of Alzheimer's diseaseCytochrome P450s in the synthesis of cholesterol and bile acids--from mouse models to human diseases.Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's diseaseBACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's diseaseNo genetic association between ATP binding cassette proteins and Japanese sporadic Alzheimer's diseaseMidlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based studyEffects of Copper and/or Cholesterol Overload on Mitochondrial Function in a Rat Model of Incipient NeurodegenerationApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosisPathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisIncreased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsHomocysteine and Real-Space Navigation Performance among Non-Demented Older Adults.Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain).Promoting successful cognitive aging: a comprehensive review.Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later.Higher incidence of mild cognitive impairment in familial hypercholesterolemia.Circulating biomarkers that predict incident dementia.Potential of ezetimibe in memory deficits associated with dementia of Alzheimer's type in mice.Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.Association of statin use with cognitive decline in elderly African Americans.Vascular risk factors and Alzheimer's disease.Association between APOE epsilon4 allele and vascular dementia: The Cache County studyThe blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease
P2860
Q22241490-A4DC8D8D-5287-4A50-B7AF-98F2089466CDQ22241658-100D1DD9-E5FD-4AB8-BC84-307379855681Q22242643-F4F5284E-5386-4E58-8640-6B4D45AABBE6Q24186591-3500C37B-83FE-43A5-B245-F4930F4278CDQ24194901-60DB51B8-CC11-4FC8-B6D3-1127CDAF76B3Q24236484-BFB1918B-098C-49C6-8788-815C06C757F8Q24241335-0513DDD1-CD26-4347-881A-0B5C0A593E00Q24298652-6E526C8A-208D-4A73-94AD-7DA54E87AE4EQ24642517-BC7DB47C-125E-43FB-B187-6114BC021C5DQ24646877-D20610BF-8F45-4F7E-8068-1BAF3666126FQ24798481-484B2FE5-3B23-46A3-81D0-AC64A9B4BFB3Q26865589-A6DB30B6-C3BA-4E2D-B476-2F8240F239D2Q27008997-DB5DCD3A-0932-408E-8A8E-9BF0F9B12720Q27022259-68E658A5-A942-43D4-8BEB-B35C14257891Q27301438-A566C783-D854-44C8-A8AD-A5187D6F596DQ27323892-4578E1D3-8FF9-4901-83F3-46B0993C317EQ27687289-CA33EF4F-13AD-4661-AC20-D75190B3D63BQ28201917-5404E184-7A17-4501-A5B0-C9EED705FFF0Q28257726-4A7E698C-3B2C-4963-B8BC-ED1D27F5687CQ28258393-C90E68E0-F2D2-44CF-BE51-01A5A6F7F01BQ28366850-7D1F3952-33F0-4B5B-A01C-5E2461D0AE21Q28391507-8228FDCC-54F4-45A5-81A2-A0BF04E0CF8AQ28504715-A7AF3AC0-3B57-4D65-B5D4-34C058533673Q30235369-7B2AF425-A8F5-4CB4-A71F-D2173DF28F94Q30484210-3D379F0C-4918-4237-B205-085DC3256E74Q30814231-44753774-4258-4689-BEF8-B83C5492A386Q31140389-8DADFE7D-A3D6-42F7-A580-30C3036AC9B5Q33358995-5768501F-8C47-4227-B9B5-2FF03ED21BAAQ33376859-C25AEE8C-7949-4433-BAB8-10D60407910EQ33544151-36592E27-6A6B-4ABF-8B66-99A1635DCBA4Q33621287-CCD9DC62-93DD-4D2A-88D1-A00A66303DB6Q33750064-F1080282-3436-4D18-9F23-31BE22AE7E34Q33752058-4858214F-F9C7-4D6C-9994-D3E8179F07E3Q33757184-99F0AA42-7E13-4890-805A-09B95261CC74Q33790425-EBE7FF59-9ABA-46D9-8A55-1EFB4CB2703DQ33802886-94F521BA-2409-4525-922D-58D7728FE82DQ33808042-6EEABF70-ED05-482C-9EFF-1F2D08B48DC2Q33832935-7FDD2A03-E56A-4E0F-A6F8-DA9EFBCDEA8FQ33836213-3611D3B0-47B5-4267-BAAE-448399D6DCA9Q33861622-4A75E37E-F668-4DF4-B5A8-F8C164223B6C
P2860
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
description
1998 nî lūn-bûn
@nan
1998 թուականին հրատարակուած գիտական յօդուած
@hyw
1998 թվականին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@ast
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@en
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@nl
type
label
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@ast
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@en
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@nl
prefLabel
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@ast
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@en
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@nl
P2093
P3181
P356
P1433
P1476
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
@en
P2093
A Nissinen
I L Notkola
J Pekkanen
T Erkinjuntti
P3181
P356
10.1159/000026149
P407
P577
1998-01-01T00:00:00Z